From: In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival
Untreated/ Chemo
RR/Chemo
Untreated/ASCT
RR/ASCT
High VDJ%
16
24
28
1
Low VDJ%
25
21
0
Total
40
49